Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Take Our 5-Minute Quiz to See if You Qualify. Free Shipping on All Medications

Oral Semaglutide

Understanding Oral Semaglutide: An Effective Tool for Weight Management and Diabetes

Christine Folake Obasi-Coon, PharmD

Licensed Pharmacist, Owner and Lead Pharmacist at Sit Laus Deo (SLD) Compounding Pharmacy in Houston, TX

With expertise in compounding pharmacy and medical weight loss medications, Christine is dedicated to providing personalized and high-quality pharmaceutical care to her patients.

Content reviewed for pharmaceutical accuracy by our clinical team

Semaglutide Overview

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications that work by mimicking the effects of the naturally occurring hormone GLP-1. As a GLP-1 agonist, semaglutide increases insulin secretion, reduces appetite, and slows gastric emptying, making it an effective treatment for both type 2 diabetes and obesity.

Semaglutide's dual role in managing these conditions stems from its ability to regulate blood sugar levels and promote weight loss. By stimulating insulin release and reducing appetite, semaglutide helps lower blood glucose levels in individuals with type 2 diabetes. Additionally, its appetite-suppressing effects and delayed gastric emptying contribute to weight loss, making it a valuable tool for individuals seeking to manage their weight.

Oral Semaglutide Effectiveness Timeline

The timeline for experiencing the effects of oral semaglutide can vary depending on several factors, including the individual's dosage, lifestyle, and overall health history. However, many patients begin to notice initial results within the first few weeks of treatment.

Initial Results

Typically, patients may start to experience a reduction in appetite and a feeling of fullness after meals within the first 2-4 weeks of starting oral semaglutide treatment. This early appetite suppression can contribute to gradual weight loss over time.

Continued Progress

As treatment progresses, the full effects of semaglutide become more apparent. Clinical studies have shown that patients can expect to see substantial weight loss and improvements in blood sugar control within the first 3-6 months of consistent treatment.

For example, in a study published in the New England Journal of Medicine, patients with type 2 diabetes who received semaglutide experienced an average weight loss of 6.5% of their initial body weight after 68 weeks of treatment.

Long-Term Maintenance

Consistent adherence to oral semaglutide treatment is crucial for maintaining long-term results. While individual responses may vary, many patients experience continued weight loss and improved glycemic control as long as they remain on the medication.

It's important to note that factors such as dietary habits, exercise routines, and overall lifestyle can influence the rate and extent of weight loss and blood sugar management with semaglutide. For optimal results, healthcare providers often recommend combining semaglutide with lifestyle modifications, such as a healthy diet and regular physical activity.

Clinical Studies and Proven Outcomes

Oral semaglutide has been extensively studied in clinical trials, demonstrating its effectiveness for both weight management and diabetes control.

Weight Loss Outcomes

In the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program, which included individuals with obesity or overweight with comorbidities, semaglutide showed significant weight loss results compared to placebo.

According to the study published in the New England Journal of Medicine, participants who received semaglutide lost an average of 14.9% of their initial body weight after 68 weeks of treatment, compared to a 2.4% weight loss in the placebo group.

Diabetes Management Outcomes

Semaglutide has also proven effective in improving glycemic control in individuals with type 2 diabetes. The SUSTAIN (Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes) clinical trial program evaluated semaglutide's efficacy in reducing HbA1c levels, a measure of long-term blood sugar control.

In one study from the SUSTAIN program, published in The Lancet Diabetes & Endocrinology, semaglutide demonstrated a significant reduction in HbA1c levels compared to placebo, with an average decrease of 1.5% from baseline.

Comparative Effectiveness

When compared to other medications used for weight management or diabetes control, semaglutide has shown superior or comparable effectiveness in many cases.

For example, in a head-to-head study published in the Journal of the American Medical Association (JAMA), semaglutide was found to be more effective for weight loss than liraglutide, another GLP-1 agonist, with an average weight loss of 9.6% versus 5.7% after 68 weeks of treatment.

Managing Side Effects and Safety Considerations

Like many medications, oral semaglutide can cause side effects in some patients. The most commonly reported side effects include nausea, diarrhea, constipation, vomiting, and abdominal pain.

Minimizing Side Effects

Healthcare providers often recommend starting with a low dose of semaglutide and gradually increasing it over several weeks or months to help minimize the occurrence and severity of side effects. Additionally, taking semaglutide with food or slowly increasing fluid intake can help alleviate gastrointestinal side effects.

Precautions and Contraindications

Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2). It should also be used with caution in patients with renal impairment, as dose adjustments may be necessary.

As with any medication, it's essential to discuss all potential risks and benefits with a healthcare provider before starting semaglutide treatment.

Overall Safety Profile

Despite the potential side effects, semaglutide has generally been well-tolerated in clinical trials, with a favorable safety profile. According to a study published in the New England Journal of Medicine, the overall rates of adverse events were similar between the semaglutide and placebo groups.

Ongoing research and post-marketing surveillance continue to monitor semaglutide's long-term safety and any potential risks.

Patient Experiences and Testimonials

While individual experiences may vary, many patients have reported positive outcomes and life-changing transformations with oral semaglutide treatment.

One patient, Sarah, shared her journey with semaglutide on the Obesity Action Coalition website: "After struggling with my weight for years, semaglutide has been a game-changer. Not only have I lost over 50 pounds, but my energy levels and overall health have improved dramatically. The medication has helped curb my appetite, and the support from my healthcare team has been invaluable."

Another patient, John, reported improved management of his type 2 diabetes with semaglutide in a testimonial on the American Diabetes Association's website: "My blood sugar levels have been much more stable since starting semaglutide. I've been able to reduce my insulin dosage, and my A1C levels have dropped significantly. It's been a relief to have better control over my diabetes."

While these experiences are positive, it's important to note that results can vary, and semaglutide may not be suitable for everyone. Patients are encouraged to discuss their individual circumstances and expectations with a healthcare provider before starting treatment.

Conclusion: A Personalized Approach to Better Health

Oral semaglutide has emerged as an effective tool for weight management and diabetes control, offering a dual approach to addressing these often interconnected health concerns. With its proven ability to promote weight loss and improve glycemic control, semaglutide provides a valuable treatment option for individuals seeking to achieve their health goals.

At MadeMed, we understand that every individual's health journey is unique. Our commitment is to provide personalized treatment plans that combine expert medical care with comprehensive lifestyle support. Through our innovative digital platform, we connect you with licensed healthcare providers who will evaluate your specific needs and determine if oral semaglutide is the right fit for you.

If you're considering oral semaglutide or exploring weight management and diabetes treatment options, we invite you to schedule a consultation with our team. Together, we'll embark on a personalized approach to better health, guided by the latest medical advancements and tailored to your individual circumstances.

Remember, health is a lifelong journey, and MadeMed is here to support you every step of the way, empowering you with the tools and guidance to achieve your wellness goals.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.

*Based on a 78-week clinical trial; patients without diabetes lost with a BMI of ≥30, or ≥27 but at average of 15% of their body weight^1 (15.8 lbs) on 2.4 mg semaglutide, when combined with a reduced-calorie diet and increased physical activity. Individual results may vary.